✦ LIBER ✦

Clinical evaluation of lobenzarit (CCA), a non-antiinflammatory immunomodulative, in rheumatoid arthritis (RA). A multicenter, double-blind, placebo-controlled study

✍ Scribed by Yuichi Shiokawa

Publisher: Elsevier Science
Year: 1982
Tongue: English
Weight: 66 KB
Volume: 4
Category: Article
ISSN: 0192-0561
DOI: 10.1016/0192-0561(82)90263-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a multicenter placebo-control

Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma

✍ E. M. Lemmel; D. Brackertz; M. Franke; W. Gaus; P. W. Hartl; K. Machalke; H. Mie 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 660 KB

In a multicenter placebo-controlled double-blind randomized clinical study, 91 patients with rheumatoid arthritis were given 28 days' treatment with recombinant interferon-gamma (50 micrograms daily for 20 days, then 50 micrograms each second day up to day 28, given by subcutaneous injection). The a

The relationship of serum infliximab con

The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial

✍ E. William St.Clair; Carrie L. Wagner; Adedigbo A. Fasanmade; Benjamin Wang; Tho 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Abstract ## Objective To investigate the relationship between serum concentrations of infliximab, a monoclonal anti–tumor necrosis factor α antibody, and clinical improvement from infliximab therapy for rheumatoid arthritis (RA). ## Methods Multiple blood samples were obtained from each of 42

Atacicept in patients with rheumatoid ar

Atacicept in patients with rheumatoid arthritis: Results of a multicenter, phase ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study

✍ P. P. Tak; R. M. Thurlings; C. Rossier; I. Nestorov; A. Dimic; V. Mircetic; M. R 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

A 48-week, randomized, double-blind, dou

A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: Results of the METGO study

✍ Allen J. Lehman; John M. Esdaile; Alice V. Klinkhoff; Eric Grant; Avril Fitzgera 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 3 views

Effect of folic or folinic acid suppleme

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: A forty-eight–week, multicenter, randomized, double-blind, placebo-controlled study

✍ Annelies E. Van Ede; Roland F. J. M. Laan; Maarten J. Rood; Tom W. J. Huizinga; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 3 views

Efficacy, pharmacodynamics, and safety o

Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: Results of two randomized, double-blind, placebo-controlled clinical studies

✍ Nemanja Damjanov; Robert S. Kauffman; George T. Spencer-Green 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views